K+S Breaks Free from Downtrend as Analyst Split Widens Ahead of Earnings

K+S shares break downtrend and cross 100-day moving average, up 17.68% YTD, as potash prices lift earnings despite divided analyst ratings.

The potash and salt producer K+S has staged a technical breakout that is drawing attention from market technicians, even as the analyst community remains deeply divided on the stock’s prospects. The shares climbed out of a downtrend that had been in place since March, crossing above the 100-day moving average on 28 July — a milestone that chart watchers treat as a confirmation of the reversal that began in mid-July.

That initial move came on a single trading session when the stock surged nearly 5 percent, snapping the downward channel. The subsequent breach of the 100-day line added further conviction to the turnaround story. At €14.71, the shares are up 17.68 percent since the start of the year, a sharp improvement from the lows that had weighed on sentiment through the spring. Still, the stock remains well below its 52-week peak of €18.31.

The technical recovery has been underpinned by a clear improvement in the company’s operating performance. First-quarter EBITDA jumped 39 percent year-on-year to €279 million, driven largely by firmer potash prices. In the key Brazilian market, the price of potassium chloride climbed above $400 per tonne by early May, and management expects that level to hold, with spillover effects anticipated in other regions including Europe.

The fertiliser market is currently telling two different stories. Nitrogen-based fertilisers are seeing price declines amid the ongoing grain harvest, but potash is moving in the opposite direction, with producers already pushing prices higher. That resilience in the potash segment is widely seen as a key factor behind the recent lift in K+S shares.

A House Divided

On Tuesday, a sharp upgrade from Exane BNP Paribas sent the stock surging 6.5 percent. By Wednesday, the shares had settled back slightly to €14.74, a marginal 0.20 percent decline — a consolidation that felt almost routine after the spike. The move echoed an earlier episode on 13 July, when the stock gained 3.35 percent despite an “Underperform” rating from Jefferies. Twice in a matter of weeks, the share price has run away from the bears.

The analyst consensus remains stubbornly neutral. Of the 13 houses tracked, four rate the stock a Buy, four a Hold, and five a Sell. That split leaves no clear signal — just an open dispute between optimists and sceptics. Notably, Tuesday’s jump was a solo act. The broader chemicals and commodities sector was mixed to weak at the same time, confirming that the catalyst came from within the company, not from a sector-wide recovery.

The Numbers Are Turning

On a twelve-month view, K+S still shows a loss, but the trajectory is improving. For the second quarter, the consensus is for a return to profitability, with earnings per share of around €0.10 on revenue of €914.5 million — a clear improvement from the loss recorded in the first quarter. Estimates for the coming twelve months have also shifted dramatically. Just a few weeks ago, analysts were forecasting a loss of €0.29 per share. That has now flipped to a profit of €0.16 per share, a swing of roughly 154 percent.

In the spring, K+S raised its full-year EBITDA guidance to a range of €630 million to €730 million, up from the previous €600 million to €700 million. That upward revision gave the bulls fresh ammunition, even as the bears continued to question the sustainability of the recovery.

The Verdict Comes on 12 August

The real test is still ahead. K+S will release its half-year results before the market opens on 12 August 2026, and that is where the debate between optimists and sceptics will be settled — at least for now. Given the sharply divided analyst opinions, market participants are bracing for elevated volatility around the release. The stock’s annualised volatility of 26.28 percent already reflects that uncertainty.

From a chart perspective, the relative strength index stands at 64, indicating there is still room to run before the stock becomes overbought. That leaves the door open for further upside if the fundamental turnaround is confirmed in the numbers. Until then, the shares are likely to remain choppy, with the 100-day moving average serving as the key short-term reference point. A sustained hold above that level would confirm that the March downtrend has truly reversed. A slip back below would reopen the questions that the recent rally had seemed to answer.